These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 12622322

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers.
    Makarounas-Kirchmann K, Glover-Koudounas S, Ferrari P.
    Clin Ther; 2009 Aug; 31(8):1652-63. PubMed ID: 19808126
    [Abstract] [Full Text] [Related]

  • 3. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M, Pruijm M, Wuerzner G.
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [Abstract] [Full Text] [Related]

  • 4. Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives.
    Leonetti G, Magnani B, Pessina AC, Rappelli A, Trimarco B, Zanchetti A, COHORT Study Group.
    Am J Hypertens; 2002 Nov; 15(11):932-40. PubMed ID: 12441211
    [Abstract] [Full Text] [Related]

  • 5. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
    Chaugai S, Sherpa LY, Sepehry AA, Kerman SRJ, Arima H.
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
    [Abstract] [Full Text] [Related]

  • 6. Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine.
    Lund-Johansen P, Stranden E, Helberg S, Wessel-Aas T, Risberg K, Rønnevik PK, Istad H, Madsbu S.
    J Hypertens; 2003 May; 21(5):1003-10. PubMed ID: 12714876
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety evaluation of lacidipine compared with amlodipine in mild-to-moderate hypertensive patients.
    Lombardo D, Raimondi F.
    J Cardiovasc Pharmacol; 1994 May; 23 Suppl 5():S98-100. PubMed ID: 7609517
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lercanidipine in the treatment of hypertension.
    Beckey C, Lundy A, Lutfi N.
    Ann Pharmacother; 2007 Mar; 41(3):465-73. PubMed ID: 17341540
    [Abstract] [Full Text] [Related]

  • 11. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH, Park SJ, Kim EJ, Kim SJ, Cho HJ, Song JM, Shin J, Park JJ, Shin JH, Han KR, Choi DJ.
    Trials; 2018 Jun 20; 19(1):324. PubMed ID: 29925421
    [Abstract] [Full Text] [Related]

  • 12. [Third generation of calcium antagonists: focus on lacidipine].
    Sidorenko BA, Stetsenko TM, Preobrazhenskiĭ DV, Savchenko MV, Soplevenko AV, Shabaeva EN.
    Kardiologiia; 2002 Jun 20; 42(12):81-90. PubMed ID: 12494025
    [Abstract] [Full Text] [Related]

  • 13. Hypertension, possible vascular protection and lercanidipine.
    Ram CV.
    Expert Rev Cardiovasc Ther; 2006 Nov 20; 4(6):783-8. PubMed ID: 17173495
    [Abstract] [Full Text] [Related]

  • 14. Lercanidipine in hypertension.
    Borghi C.
    Vasc Health Risk Manag; 2005 Nov 20; 1(3):173-82. PubMed ID: 17319103
    [Abstract] [Full Text] [Related]

  • 15. Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel.
    Shimizu H, Nakagami H, Yasumasa N, Mariana OK, Kyutoku M, Koriyama H, Nakagami F, Shimamura M, Rakugi H, Morishita R.
    Hypertens Res; 2012 Jan 20; 35(1):77-81. PubMed ID: 21881574
    [Abstract] [Full Text] [Related]

  • 16. Treatment of hypertensive patients with diabetes: beyond blood pressure control and focus on manidipine.
    Saiz Satjes M, Martinez-Martin FJ.
    Future Cardiol; 2016 Jul 20; 12(4):435-47. PubMed ID: 27221471
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison between L-type and N/L-type calcium channel blockers in the regulation of home blood-pressure variability in elderly hypertensive patients.
    Nozato S, Yamamoto K, Nozato Y, Takeda M, Hongyo K, Takeya M, Akasaka H, Takami Y, Takeya Y, Sugimoto K, Ito N, Rakugi H.
    Hypertens Res; 2018 Apr 20; 41(4):290-298. PubMed ID: 29449705
    [Abstract] [Full Text] [Related]

  • 20. Ankle edema formation during treatment with the calcium channel blockers lacidipine and amlodipine: a single-centre study.
    Andrésdóttir MB, van Hamersvelt HW, van Helden MJ, van de Bosch WJ, Valk IM, Huysmans FT.
    J Cardiovasc Pharmacol; 2000 Apr 20; 35(3 Suppl 1):S25-30. PubMed ID: 11347858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.